Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Breyer, Johannes"" wg kryterium: Autor


Wyświetlanie 1-10 z 10
Tytuł :
Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy.
Autorzy :
Martini T; Department of Urology, University of Ulm, Ulm, Germany. Electronic address: .
Heinkele J; Department of Urology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Mayr R; Department of Urology, University of Regensburg, Caritas St. Josef Medical Center, Germany.
Weis CA; Institute of Pathology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Wezel F; Department of Urology, University of Ulm, Ulm, Germany.
Wahby S; Department of Urology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Eckstein M; Institute of Pathology, University of Erlangen-Nüremberg, Erlangen, Germany.
Schnöller T; Department of Urology, University of Ulm, Ulm, Germany.
Breyer J; Department of Urology, University of Regensburg, Caritas St. Josef Medical Center, Germany.
Wirtz R; STRATIFYER Molecular Pathology GmbH, Cologne, Germany; Institute of Pathology, The St. Elisabeth Hospital Köln-Hohenlind, Cologne, Germany.
Ritter M; Department of Urology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Bolenz C; Department of Urology, University of Ulm, Ulm, Germany.
Erben P; Department of Urology, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany. Electronic address: .
Pokaż więcej
Źródło :
Urologic oncology [Urol Oncol] 2018 Dec; Vol. 36 (12), pp. 530.e19-530.e27. Date of Electronic Publication: 2018 Nov 13.
Typ publikacji :
Journal Article
MeSH Terms :
Cell Proliferation*
Lymphangiogenesis*
Biomarkers, Tumor/*genetics
Cystectomy/*adverse effects
Neoplasm Recurrence, Local/*surgery
RNA, Messenger/*genetics
Urinary Bladder Neoplasms/*surgery
Aged ; Aged, 80 and over ; Biomarkers, Tumor/metabolism ; Cohort Studies ; Female ; Follow-Up Studies ; GTPase-Activating Proteins/genetics ; GTPase-Activating Proteins/metabolism ; Humans ; Ki-67 Antigen/genetics ; Ki-67 Antigen/metabolism ; Lymphatic Metastasis ; Male ; Middle Aged ; Neoplasm Invasiveness ; Neoplasm Recurrence, Local/pathology ; Predictive Value of Tests ; RNA, Messenger/metabolism ; Survival Rate ; Urinary Bladder Neoplasms/pathology ; Vascular Endothelial Growth Factor C/genetics ; Vascular Endothelial Growth Factor C/metabolism ; Vascular Endothelial Growth Factor D/genetics ; Vascular Endothelial Growth Factor D/metabolism ; Vascular Endothelial Growth Factor Receptor-3/genetics ; Vascular Endothelial Growth Factor Receptor-3/metabolism
Czasopismo naukowe
Tytuł :
ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ.
Autorzy :
Breyer J; Department of Urology, University of Regensburg, Regensburg, Germany.
Otto W
Wirtz RM
Wullich B
Keck B
Erben P
Kriegmair MC
Stoehr R
Eckstein M
Laible M
Schlombs K
Eidt S
Denzinger S
Burger M
Hartmann A
Pokaż więcej
Corporate Authors :
BRIDGE Consortium
Źródło :
Urologia internationalis [Urol Int] 2017; Vol. 98 (3), pp. 282-289. Date of Electronic Publication: 2016 Dec 17.
Typ publikacji :
Journal Article
MeSH Terms :
Cystectomy*
Gene Expression Regulation, Neoplastic*
Carcinoma in Situ/*metabolism
Receptor, ErbB-2/*metabolism
Urinary Bladder Neoplasms/*metabolism
Aged ; Carcinoma in Situ/surgery ; Disease Progression ; Disease-Free Survival ; Estrogen Receptor alpha/metabolism ; Female ; Humans ; Kaplan-Meier Estimate ; Ki-67 Antigen/metabolism ; Male ; Middle Aged ; Predictive Value of Tests ; Prognosis ; Proportional Hazards Models ; RNA, Messenger/metabolism ; RNA, Neoplasm/analysis ; Receptor, ErbB-2/genetics ; Receptors, Progesterone/metabolism ; Retrospective Studies ; Sensitivity and Specificity ; Treatment Outcome ; Urinary Bladder Neoplasms/surgery
Czasopismo naukowe
Tytuł :
Outcome of patients with pathological tumor stage T3 urothelial carcinoma of the bladder following radical cystectomy in a single-center series with 116 patients.
Autorzy :
Breyer J; Department of Urology, Caritas St. Josef Medical Center, University of Regensburg, Regensburg, Germany.
Denzinger S
Otto W
Bründl J
Gierth M
Fritsche HM
Rößler W
Wieland WF
Giedl C
Hofstädter F
Rubenwolf P
Burger M
Aziz A
Pokaż więcej
Źródło :
Urologia internationalis [Urol Int] 2014; Vol. 93 (3), pp. 311-9. Date of Electronic Publication: 2014 Sep 04.
Typ publikacji :
Journal Article
MeSH Terms :
Cystectomy/*mortality
Urinary Bladder Neoplasms/*surgery
Urothelium/*surgery
Aged ; Aged, 80 and over ; Antigens, CD ; Cadherins/metabolism ; Chemotherapy, Adjuvant ; Disease-Free Survival ; Female ; Humans ; Immunohistochemistry ; Kaplan-Meier Estimate ; Lymph Nodes/pathology ; Male ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Staging ; Proportional Hazards Models ; Retrospective Studies ; Treatment Outcome ; Urinary Bladder Neoplasms/mortality
Czasopismo naukowe
Tytuł :
Validation of a German translation of the CARE questionnaire and its implementation as electronic PROM to assess patient-reported postoperative convalescence and recovery after major urological surgery
Autorzy :
Wessels, Frederik
Lenhart, Maximilian
Neuberger, Manuel
Mühlbauer, Julia
Huber, Johannes
Breyer, Johannes
Nuhn, Philipp
Michel, Maurice S.
Koenig, JulianAff4, Aff5
Kriegmair, Maximilian C.
Pokaż więcej
Źródło :
World Journal of Urology. :1-13
Czasopismo naukowe
Tytuł :
The comprehensive complication index is associated with a significant increase in complication severity between 30 and 90 days after radical cystectomy for bladder cancer.
Autorzy :
Haas, Maximilian
Huber, Toni
Pickl, Christoph
van Rhijn, Bas W.G.
Gužvić, Miodrag
Gierth, Michael
Breyer, Johannes
Burger, Maximilian
Mayr, Roman
Pokaż więcej
Temat :
URINARY diversion
BLADDER cancer
CYSTECTOMY
MEDICAL records
REGRESSION analysis
BLADDER
Źródło :
European Journal of Surgical Oncology; May2021, Vol. 47 Issue 5, p1163-1171, 9p
Czasopismo naukowe
Tytuł :
FOXM1 overexpression is associated with adverse outcome and predicts response to intravesical instillation therapy in stage pT1 non‐muscle‐invasive bladder cancer.
Autorzy :
Breyer, Johannes johannes.breyer@ukr.de
Wirtz, Ralph M.
Erben, Philipp
Rinaldetti, Sebastien
Worst, Thomas S.
Stoehr, Robert
Eckstein, Markus
Sikic, Danijel
Denzinger, Stefan
Burger, Maximilian
Hartmann, Arndt
Otto, Wolfgang
Pokaż więcej
Źródło :
BJU International. Jan2019, Vol. 123 Issue 1, p187-196. 10p.
Czasopismo naukowe
Tytuł :
FOXA1 Gene Expression for Defining Molecular Subtypes of Muscle-Invasive Bladder Cancer after Radical Cystectomy.
Autorzy :
Sikic, Danijel
Eckstein, Markus
Wirtz, Ralph M.
Jarczyk, Jonas
Worst, Thomas S.
Porubsky, Stefan
Keck, Bastian
Kunath, Frank
Weyerer, Veronika
Breyer, Johannes
Otto, Wolfgang
Rinaldetti, Sebastien
Bolenz, Christian
Hartmann, Arndt
Wullich, Bernd
Erben, Philipp
Pokaż więcej
Temat :
BLADDER cancer
GENE expression
CYSTECTOMY
POLYMERASE chain reaction
PROGRESSION-free survival
Źródło :
Journal of Clinical Medicine; Apr2020, Vol. 9 Issue 4, p994, 1p
Czasopismo naukowe
Tytuł :
Erratum to 'Predictive value of lymphangiogenesis and proliferation markers on mRNA level in urothelial carcinoma of the bladder after radical cystectomy' [Urologic Oncology: Seminars and Original Investigations 36/12 (2018) 505-534].
Autorzy :
Martini, Thomas (AUTHOR)
Heinkele, Jakob (AUTHOR)
Mayr, Roman (AUTHOR)
Weis, Cleo-Aron (AUTHOR)
Wezel, Felix (AUTHOR)
Wahby, Sarah (AUTHOR)
Eckstein, Markus (AUTHOR)
Schnöller, Thomas (AUTHOR)
Breyer, Johannes (AUTHOR)
Wirtz, Ralph (AUTHOR)
Ritter, Manuel (AUTHOR)
Bolenz, Christian (AUTHOR)
Erben, Philipp (AUTHOR)
Pokaż więcej
Źródło :
Urologic Oncology. Mar2019, Vol. 37 Issue 3, p227-227. 1p.
Czasopismo naukowe
    Wyświetlanie 1-10 z 10

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies